This is the authors' abstract. We don't add key points for this paper.
Alterations were made in the amino terminus and the first two transmembrane-spanning regions of the latent membrane protein-1 (LMP-1) of Epstein-Barr virus. These mutant proteins were tested for their abilities to patch and to stimulate NF-kappaB activity. A subset of these derivatives retains the wild-type topology of LMP-1 in the plasma membrane, but has lost the ability to patch. Deletion of residues 9-20 of LMP-1, which contain potential SH3-binding motifs, abrogates patching of LMP-1. However, mutation of the prolines within these motifs, which eliminates binding of LMP-1 to SH3 domains in vitro, does not prevent patching by LMP-1. Deletion of the first two transmembrane regions of LMP-1 does prevent it patching. Some of the derivatives of LMP-1 which do not patch do stimulate NF-kappaB activity. Patching by LMP-1 appears to be a higher-order assemblage of protein that is compatible with the stimulation of NF-kappaB activity but is not necessary for this signalling.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bloss et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: